TP53 and cancer: To ensure cell survival upon centriole number manipulation, and to mimic what occurs in cancer, where the tumor suppressor p53 is often mutated, we successfully knocked out (KO) p53 in the MCF10A-Plk4 cells by using the CRISPR/Cas9 technology (Supplementary Fig. 1).